Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

06Jun 2022

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference

24May 2022

Amphastar Receives FDA Approval for Regadenoson


Financial Calendar

08Jun 2022

Jefferies Healthcare Conference

Add to Calendar
09May 2022

Amphastar First Quarter Earnings Call

Add to Calendar
12Apr 2022

21st Annual Needham Virtual Healthcare Conference

Add to Calendar
10Mar 2022

Amphastar Fourth Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.